Xu Ran
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Drug DiscoveryGoogle:
"Xu Ran"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nadel CM, Ran X, Gestwicki JE. (2020) Luminescence Complementation Assay for Measurement of Binding to Protein C-Termini in Live Cells. Analytical Biochemistry. 113947 |
Zhao Y, Zhou B, Bai L, et al. (2018) Structure-Based Discovery of CF53 as a Potent and Orally Bioavailable Bromodomain and Extra-Terminal (BET) Bromodomain Inhibitor. Journal of Medicinal Chemistry |
Ran X, Gestwicki JE. (2018) Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area. Current Opinion in Chemical Biology. 44: 75-86 |
Ran X, Burchfiel ET, Dong B, et al. (2018) Rational design and screening of peptide-based inhibitors of heat shock factor 1 (HSF1). Bioorganic & Medicinal Chemistry |
Taylor IR, Dunyak BM, Komiyama T, et al. (2018) High Throughput Screen for Inhibitors of Protein-Protein Interactions in a Reconstituted Heat Shock Protein 70 (Hsp70) Complex. The Journal of Biological Chemistry |
Karatas H, Li Y, Liu L, et al. (2017) Discovery of a Highly Potent, Cell-Permeable Macrocyclic Peptidomimetic (MM-589) Targeting the WD Repeat Domain 5 Protein (WDR5)-Mixed Lineage Leukemia (MLL) Protein-Protein Interaction. Journal of Medicinal Chemistry |
Zhao Y, Bai L, Liu L, et al. (2017) Structure-Based Discovery of 4-(6-Methoxy-2-methyl-4-(quinolin-4-yl)-9H-pyrimido[4,5-b]indol-7-yl)-3,5-dimethylisoxazole (CD161) as a Potent and Orally Bioavailable BET Bromodomain Inhibitor. Journal of Medicinal Chemistry |
Ran X, Liu L, Yang C, et al. (2015) Design of High-affinity Stapled Peptides to Target the Repressor Activator Protein 1 (RAP1)/Telomeric Repeat-binding Factor 2 (TRF2) Protein-Protein Interaction in the Shelterin Complex. Journal of Medicinal Chemistry |
Ran X, Zhao Y, Liu L, et al. (2015) Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors. Journal of Medicinal Chemistry. 58: 4927-39 |
Kurokawa M, Kim J, Geradts J, et al. (2013) A network of substrates of the E3 ubiquitin ligases MDM2 and HUWE1 control apoptosis independently of p53. Science Signaling. 6: ra32 |